Life sciences visits the ATM

U.S. life sciences companies raised a record $90 million through at-the-market (ATM) offerings in 1Q12, according to data from ATM specialist Brinson Patrick Securities Corp. That's a 36% increase over 1Q11, which previously had the highest amount raised at $66 million. Companies raised the money through 20 ATMs last quarter and 22 ATMs in 1Q11. ...